Position in ACLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$62,488,144
+$59,828,571 QoQ
Shares Held
544,227
+1234.2% QoQ
Ownership
0.931%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in ACLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ALLIANCEBERNSTEIN L.P. holds $5,113,566,936 across 211 Biotechnology names. ACLX ranks #18 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,910,786 | $1,746,322,380 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
426,914 | $329,850,832 | |
| 3 | ARGX |
Argenx SE
|
422,304 | $308,387,496 | |
| 4 | GMAB |
Genmab A/S
|
9,557,149 | $256,418,307 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
1,908,907 | $141,755,433 | |
| 6 | TECH |
BIO-TECHNE Corp
|
2,213,197 | $115,661,675 | |
| 7 | INSM |
INSMED Inc
|
688,734 | $112,621,783 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
1,736,501 | $112,230,059 |
All Filings in ACLX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $62,488,144 | 544,227 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,659,573 | 40,791 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,803,446 | 46,327 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,171,006 | 48,155 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,364,952 | 51,295 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,930,362 | 51,250 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $4,796,062 | 57,431 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,080,209 | 55,811 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,752,789 | 39,580 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,053,500 | 37,000 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,299,214 | 36,210 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,144,960 | 36,210 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $822,627 | 26,700 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $827,166 | 26,700 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $403,555 | 21,500 | Shares | Defined | 2022-11-15 | |
| No filing history on record for this holder in this stock. | ||||||